Padcev (enfortumab vedotin)

enfortumab vedotin · Seagen Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Padcev (enfortumab vedotin), covering 2025-07-28 to 2025-09-18. Get the full timeline:

Most recent: Clinical Trial Update: PLUG-IN: Pembrolizumab Combined With Enfortumab Vedotin for Advanced Melanoma Patients [Phase 2]